Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 9, Issue 5, Pages 713-721
Publisher
Informa Healthcare
Online
2010-08-19
DOI
10.1517/14740331003742935
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dasatinib
- (2009) Susan J Keam BIODRUGS
- Optimising chronic myeloid leukaemia therapy in the face of resistance to tyrosine kinase inhibitors – A synthesis of clinical and laboratory data
- (2009) David A. Irvine et al. BLOOD REVIEWS
- Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure
- (2009) Alfonso Quintás-Cardama et al. CANCER
- Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion
- (2009) Kimmo Porkka et al. CANCER
- Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia
- (2009) D. Milojkovic et al. CLINICAL CANCER RESEARCH
- Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A Trial
- (2009) Jane F. Apperley et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia
- (2009) Jorge E. Cortes et al. JOURNAL OF CLINICAL ONCOLOGY
- Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
- (2009) F J Giles et al. LEUKEMIA
- Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy
- (2009) S Mustjoki et al. LEUKEMIA
- Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation
- (2009) Sunday Ocheni et al. LEUKEMIA & LYMPHOMA
- Treatment selection after imatinib resistance in chronic myeloid leukemia
- (2009) Elias Jabbour et al. Targeted Oncology
- Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors
- (2009) Kevin Kelly et al. Targeted Oncology
- Molecular biology of bcr-abl1-positive chronic myeloid leukemia
- (2008) A. Quintas-Cardama et al. BLOOD
- Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia
- (2008) K. Porkka et al. BLOOD
- Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis
- (2008) Hugues de Lavallade et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate
- (2008) M. Brave et al. CLINICAL CANCER RESEARCH
- New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check
- (2008) Thomas O'Hare et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Finding of Kinase Domain Mutations in Patients With Chronic Phase Chronic Myeloid Leukemia Responding to Imatinib May Identify Those at High Risk of Disease Progression
- (2008) Jamshid S. Khorashad et al. JOURNAL OF CLINICAL ONCOLOGY
- Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia
- (2008) Neil P. Shah et al. JOURNAL OF CLINICAL ONCOLOGY
- Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
- (2008) A Hochhaus et al. LEUKEMIA
- Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase
- (2008) J Cortes et al. LEUKEMIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started